Actually, many studies have reported that CREB/BDNF activation in the brain of experimental mice facilitates successful memory retrieval (Weon et al., 2016; Wang et al., 2018; Ma et al., 2019), implying that enhancers of CREB/BDNF pathway may have the potential for treatment of AD. This evidence concerns the gene CREB1 and Alzheimer disease.